| Literature DB >> 29327286 |
Lukas Mayer1, Julia Ferrari2, Stefan Krebs2, Christian Boehme1, Thomas Toell1, Benjamin Matosevic3, Alexander Tinchon4, Michael Brainin5, Thomas Gattringer6, Peter Sommer7, Peter Thun8, Johann Willeit1, Wilfried Lang2, Stefan Kiechl1, Michael Knoflach9.
Abstract
Changing definition of TIA from time to a tissue basis questions the validity of the well-established ABCD3-I risk score for recurrent ischemic cerebrovascular events. We analyzed patients with ischemic stroke with mild neurological symptoms arriving < 24 h after symptom onset in a phase where it is unclear, if the event turns out to be a TIA or minor stroke, in the prospective multi-center Austrian Stroke Unit Registry. Patients were retrospectively categorized according to a time-based (symptom duration below/above 24 h) and tissue-based (without/with corresponding brain lesion on CT or MRI) definition of TIA or minor stroke. Outcome parameters were early stroke during stroke unit stay and 3-month ischemic stroke. Of the 5237 TIA and minor stroke patients with prospectively documented ABCD3-I score, 2755 (52.6%) had a TIA by the time-based and 2183 (41.7%) by the tissue-based definition. Of the 2457 (46.9%) patients with complete 3-month followup, corresponding numbers were 1195 (48.3%) for the time- and 971 (39.5%) for the tissue-based definition of TIA. Early and 3-month ischemic stroke occurred in 1.1 and 2.5% of time-based TIA, 3.8 and 5.9% of time-based minor stroke, 1.2 and 2.3% of tissue-based TIA as well as in 3.1 and 5.5% of tissue-based minor stroke patients. Irrespective of the definition of TIA and minor stroke, the risk of early and 3-month ischemic stroke steadily increased with increasing ABCD3-I score points. The ABCD3-I score performs equally in TIA patients in tissue- as well as time-based definition and the same is true for minor stroke patients.Entities:
Keywords: ABCD3-I; Minor stroke; Risk prediction; Time-based; Tissue-based; Transient ischemic attack
Mesh:
Year: 2018 PMID: 29327286 PMCID: PMC5834555 DOI: 10.1007/s00415-017-8720-8
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849
ABCD3- and ABCD3-I-score
| Score variables | ABCD3-score | ABCD3-I-score |
|---|---|---|
| Age ≥ 60 years | 1 | 1 |
| Blood pressure ≥ 140/90 mmHg | 1 | 1 |
| Clinical features of TIA | ||
| Speech impairment only | 1 | 1 |
| Unilateral weakness | 2 | 2 |
| Duration of TIA | ||
| 10–59 min | 1 | 1 |
| ≥ 60 min | 2 | 2 |
| Diabetes mellitus present | 1 | 1 |
| Dual TIAa | 2 | 2 |
| Imaging criteria | ||
| Ipsilateral ≥ 50% ICA stenosis | – | 2 |
| Acute diffusion-weighted imaging hyperintensity | – | 2 |
| Total range of score points | 0–9 | 0–13 |
aTIA prompting medical attention plus at least one other TIA in the preceding 7 days
Characteristics of the whole study population and of subgroups dependent on time- or tissue-based definition of TIA and minor stroke (MS)
| All | Time-based TIA | Time-based MS | Tissue-based TIA | Tissue-based MS | |
|---|---|---|---|---|---|
| Number of patients | 5237 | 2755 | 2482 | 2183 | 3054 |
| Age, median (Q1–Q3) | 71.9 (61.6–80.2) | 72.1 (61.4, 80.4) | 71.6 (61.9, 79.8) | 70.9 (59, 79.7) | 72.4 (63.2, 80.4) |
| Male sex, % ( | 55.7 (2915) | 53.5 (1473) | 58.1 (1442) | 52.9 (1154) | 57.7 (1761) |
| Hypertension, % ( | 78.5 (4113) | 76.8 (2116) | 80.5 (1997) | 72.9 (1592) | 82.5 (2521) |
| Diabetes mellitus, % ( | 23 (1203) | 21.9 (602) | 24.2 (601) | 19.7 (430) | 25.3 (773) |
| Hypercholesterolemia, % ( | 61.4 (3214) | 60.8 (1676) | 62 (1538) | 58.1 (1268) | 63.7 (1946) |
| Atrial fibrillation, % ( | 19.3 (1010) | 17.7 (487) | 21.1 (523) | 15.9 (348) | 21.7 (662) |
| Current smoking, % ( | 19.5 (1021) | 17.7 (488) | 21.5 (533) | 17.5 (382) | 20.9 (639) |
| Pre stroke mRS 0–2, % ( | 92.3 (4828) | 91.7 (2522) | 93 (2306) | 93.7 (2042) | 91.3 (2786) |
| NIHSS upon admission, median (Q1–Q3) | 1 (0, 2) | 0 (0, 2) | 2 (1, 3) | 1 (0, 2) | 2 (0, 2) |
| Onset to door time, median (Q1 | 120 (68, 255) | 108 (60, 200) | 151.5 (80, 345) | 119 (60, 230) | 130 (70, 280) |
| Stroke unit stay in days, median (Q1–Q3) | 2 (1, 3) | 2 (1, 3) | 2 (1, 4) | 2 (1, 3) | 2 (1, 4) |
| Imaging during stroke unit stay | |||||
| CT, % | 86.6 | 86.6 | 86.7 | 85.6 | 87.4 |
| MRI, % | 71.0 | 70.4 | 63.2 | 59.4 | 79.3 |
| Both, % | 56.0 | 52.4 | 59.9 | 45.6 | 63.4 |
| Early treatment | |||||
| Platelet inhibition, % | 84.9 | 85.1 | 84.7 | 86.4 | 83.9 |
| Low-dose heparin, % | 75.9 | 75.7 | 76.2 | 76.9 | 75.2 |
| Medium-to-high dose heparin, % | 15.3 | 13.0 | 17.7 | 12.4 | 17.2 |
| Secondary prevention | |||||
| Statins, % | 68.0 | 66.5 | 69.2 | 63.5 | 71.2 |
| Antihypertensive medication, % | 77.0 | 76.0 | 78.2 | 71.5 | 80.9 |
| Early stroke, % ( | 2.3 (123) | 1.1 (29) | 3.8 (94) | 1.2 (27) | 3.1 (96) |
| Early stroke AUCs (95% CI) | 0.664 (0.618–0.709) | 0.645 (0.539–0.752) | 0.605 (0.552–0.658) | 0.651 (0.546–0.756) | 0.598 (0.542–0.653) |
| 3-month stroke, % ( | 4.2 (104) | 2.5 (30) | 5.9 (74) | 2.3 (23) | 5.5 (81) |
| 3-month stroke AUCs (95% CI) | 0.646 (0.592–0.700) | 0.588 (0.487–0.688) | 0.637 (0.573–0.701) | 0.561 (0.461–0.661) | 0.619 (0.558–0.680) |
aIn those with available 3 month followup
Fig. 1Risk of early or 3-month ischemic stroke dependent on ABCD3-I score points in time- and tissue-based definition of TIA and minor stroke